Filing Details

Accession Number:
0001140361-17-032651
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-17 19:41:37
Reporting Period:
2017-08-15
Filing Date:
2017-08-17
Accepted Time:
2017-08-17 19:41:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447028 Arbutus Biopharma Corp ABUS Pharmaceutical Preparations (2834) 980597776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635324 J. Michael Sofia C/O Arbutus Biopharma Corp.
Suite 100, 8900 Glenlyon Parkway
Burnaby A1 V5J 5J8
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2017-08-15 10,000 $3.75 191,412 No 4 S Indirect Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust").
Common Shares Disposition 2017-08-15 20,000 $3.68 171,412 No 4 S Indirect Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust").
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust").
No 4 S Indirect Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust").
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 1,563,403 Direct